CATCHPOINT
Live / Registered — Registered and renewed (as of 23 Sept 2023)
What this means for you
Registered since 17 Feb 2004. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 17 Feb 2024).
Record
- Serial number
- 76513724
- Registration number
- 2814891
- Mark type
- Word mark
- Filed
- 13 May 2003
- Published for opposition
- 25 Nov 2003
- Registered
- 17 Feb 2004
- Next maintenance due
- 17 Feb 2024
- Attorney of record
- Steven A. Abreu
Goods and services
- Class 001 — Chemicals: ASSAYS, REAGENTS, AND ASSAY KITS PRIMARILY COMPRISED OF ASSAYS, REAGENTS, PLATES, BUFFERS, ANTIBODIES, CALIBRATORS, CONJUGATES, WASH SOLUTION CONCENTRATE, AND SUBSTRATE, FOR USE IN SCIENTIFIC AND MEDICAL RESEARCH
Owner
- MOLECULAR DEVICES, LLC, San Jose, CA, US
- MOLECULAR DEVICES, INC., SUNNYVALE, CA, US
- MDS ANALYTICAL TECHNOLOGIES (US) INC., SUNNYVALE, CA, US
- Molecular Devices Corporation, Sunnyvale, CA, US
- Molecular Devices Corporation, Sunnyvale, CA, US
- Molecular Devices Corporation, Sunnyvale, CA, US
Prosecution history
- 12 Nov 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 12 Nov 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 12 Nov 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 23 Sept 2023 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 23 Sept 2023 — REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
- 23 Sept 2023 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 23 Sept 2023 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 18 Mar 2023 — TEAS SECTION 8 & 9 RECEIVED
- 17 Feb 2023 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 12 Oct 2020 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 12 Oct 2020 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 12 Oct 2020 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 27 Feb 2018 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 27 Feb 2018 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 28 Feb 2014 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED